Resound Nexia vs ReSound OMNIA miniRIE

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,298. In HearAdvisor's lab testing, it earned a SoundScore of 4.0/5 and an A grade, ranking #28 of 39 prescription hearing aids tested. The Nexia demonstrates clear strengths in specific areas. Feedback handling is excellent at 5.0/5, scoring 0.28 points above the category average—users can expect stable performance without whistling during typical daily activities. Own-voice comfort also stands out at 3.6/5, a solid score that sits 0.90 points above average, suggesting wearers may find their own voice sounds more natural compared to many competitors. However, speech performance presents a more mixed picture. Speech in quiet measures 3.2/5—solid in absolute terms but 0.19 points below the category average. More notably, speech in noise scores just 1.0/5, falling 1.11 points below average. This represents a significant limitation for users who frequently encounter challenging listening environments like restaurants or group conversations. Music streaming scores 2.8/5, essentially matching the category average. At this price point, several alternatives deliver stronger overall performance. The Phonak Sphere Infinio, Oticon Intent, and Oticon Real all score notably higher while occupying the same premium tier. Budget-conscious buyers might also consider options like the Jabra Enhance Select 500 at a lower price point with competitive sound quality. The Nexia may be best suited for users who prioritize feedback stability and own-voice comfort over speech-in-noise performance.

The ReSound OMNIA miniRIE is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,764. In our lab testing, it earned a SoundScore of 4.0/5 (A grade), ranking #26 of 39 prescription hearing aids tested. This device demonstrates solid speech clarity in quiet environments, scoring 3.7/5—0.26 points above the category average. Own-voice comfort also measures slightly above average at 2.9/5. However, the OMNIA miniRIE struggles in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, which is 1.11 points below the category average and low in absolute terms. This represents a significant limitation for users who frequently encounter noisy environments like restaurants or social gatherings. Feedback handling is strong in absolute terms at 4.1/5, though this falls 0.62 points below the prescription hearing aid category average of 4.72/5. Music streaming performance is mixed at 2.7/5, essentially matching the category average. The device offers modern connectivity features including iPhone and Android streaming, hands-free calling, and rechargeable batteries. While the OMNIA miniRIE has earned Expert's Choice Awards in 2023 and 2024, consumers in this premium price tier should note that several competitors—including the Phonak Sphere Infinio and Oticon Intent—achieve higher overall scores. This hearing aid may be best suited for individuals who prioritize performance in quieter settings and value ReSound's ecosystem, but those needing robust noise management should explore alternatives.